Clin Res Cardiol (2022). https://doi.org/10.1007/s00392-022-02087-y

Impact of ablation index guided low power and high power short duration ablation on posterior ablation characteristics and safety in voltage guided atrial fibrillation ablation.
V. Mattea1, F. Steinborn1, M. Chapran1, K. Vathie1, N. Milisavljevic2, M. Assani1, H. Hamo1, R. Surber3, A. Lauten1, A. Schade1
1Allgemeine und Interventionelle Kardiologie und Rhythmologie, Helios-Klinikum Erfurt, Erfurt; 2Gastroenterologie/Hepatologie, Endokrinologie/Diabetologie, Rheumatologie, Onkologische Gastroenterologie, Helios Klinikum Erfurt, Erfurt; 3Klinik für Innere Medizin I - Kardiologie, Universitätsklinikum Jena, Jena;

Introduction:
Left atrial (LA) ablation using radiofrequency (RF) is a well established treatment for patients with atrial fibrillation (AF).
The aim of the study was to compare ablation data and procedural safety with a special focus on esophageal safety between contact force only guided ablation (CFG), ablation index guided low power ablation (AIG) and AI guided high power short duration ablation (AI-HPSD) for a voltage guided strategy.

Methods:
Clinical data from 76 consecutive patients undergoing ablation with 50 W AI-HPSD in whom both pulmonary vein isolation (PVI) and voltage-guided ablation were performed was compared with AIG (n=100) and CFG (n=100). AI targets were >500 anteriorly and > 350 to 400 posteriorly. Periprocedural parameters including posterior ablation characteristics and complications were analyzed.
Upper endoscopy was performed one to three days after ablation.

Results:
Baseline characteristics were comparable in all three groups (see table 1). Procedure duration (including waiting time) was significantly shorter for AI-HPSD (AI-HPSD 138±39 min vs. 193±59min in AIG; p<0.001 and 205±60 min in CFG; p<0.001). Fluoroscopy time was also significanly shorter for HPSD group
(AI-HPSD 7.7±5.3 min vs. 9.8±5.2min in AIG; p=0.01 vs. CFG 9.6±2.9 min; p=0.009).

Posterior ablation data showed that AI Max and AI Min values were less extreme in AI-HPSD and AIG versus CFG ablation. AI Max were 508±41 and 496±54 vs. 530±61; p<0.008 (CFG vs. AI-HPSD) and p=0.001 (CFG vs. AIG). AI Min were 392±49 (AI-HPSD) and 276±69 (AIG) vs. 226±58 (CFG); p<0.01 (CFG vs. AI-HPSD) and p<0.01 (CFG vs. AIG). Total posterior RF time was 4.5±1.6min for AI-HPSD and 11.9±5min for AIG vs. 15.1±5.5 min for CFG; p<0.001 (CFG vs. AI-HPSD); p<0.001 (CFG vs. AIG). Mean posterior impedance drop was significantly higher in AI-HPSD group with 8.5±2.1 vs. 7.6±2.4; p 0.02 in CFG and 7.8±2.5; p 0.05 in AIG.

Major complications occurred in 4% in each of the groups. Endoscopically detected thermal esophageal lesions (EDEL) occurred in 2.6% and 5% versus 6% (n.s.) in AI-HPSD and AIG versus CFG.

Conclusions:
AI-HPSD and AIG ablation resulted in more homogeneous lesion application at posterior wall. Although mean posterior impedance drop was higher in AI-HPSD ablation, EDEL rate was numerically lowest. Altogether, all three ablation methods showed comparable safety.



Table 1: Baseline and procedural characteristics


https://dgk.org/kongress_programme/ht2022/aP299.html